WithdrawnNot Applicable

Objective Measurement of Hearing Aid Benefit

Stopped: This study did not receive funding

0Started 2022-06

Plain-language summary

Hearing loss is a critical health concern in the rapidly aging population, affecting approximately 22 million older individuals in the United States. Yet, only 30% of individuals who would benefit from the use of hearing aids regularly use them. This project aims to improve the benefit of hearing aids for older adults through incorporation of objective neural measures to assess effects of hearing aid algorithms.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aims 1 and 2 age ranges: 18-35 and 60-75 * Aim 3 age range: 50 to 85 * Aims 1 and 2 hearing levels: 1) Normal hearing thresholds defined as pure-tone thresholds ≤ 20 decibel (dB) hearing level (HL) from 125 to 4000 Hz and ≤ 30 dB HL at 6000 and 8000 Hz bilaterally, or 2) Mild to moderate sensorineural hearing loss defined as thresholds within 5 dB of 30 dB HL at 500 Hz, 50 dB HL at 1000 and 2000 Hz, and 60 dB HL at 4000 Hz. * Aim 3 hearing level: Symmetric hearing thresholds with no interaural difference ≥ 15 dB HL at ≥ 2 frequencies. * Intelligent Quotients ≥ 85 based on the Wechsler Abbreviated Scale of Intelligence (Psychological Corp., New York) * Scores ≥ 24 on the Montreal Cognitive Assessment Exclusion Criteria: * Neurological disorders * Middle ear pathology * Nonnative English speakers

What they're measuring

Neural response fidelity

Timeframe: Immediately post-treatment

Trial details

NCT IDNCT04431622

SponsorUniversity of Maryland, College Park

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02

View on ClinicalTrials.gov More Auditory Perceptual Disorders trials